Published in Lancet on October 19, 2002
Evidence-based clinical guidelines for immigrants and refugees. CMAJ (2010) 3.57
Attitudes to HIV and HIV testing in high prevalence areas of China: informing the introduction of voluntary counselling and testing programmes. Sex Transm Infect (2005) 2.14
Cost-effectiveness of free HIV voluntary counseling and testing through a community-based AIDS service organization in Northern Tanzania. Am J Public Health (2005) 1.65
Sociocultural and epidemiological aspects of HIV/AIDS in Mozambique. BMC Int Health Hum Rights (2010) 1.64
Factors related to female sex workers' willingness to utilize VCT service: a qualitative study in Jinan city, northern China. AIDS Behav (2008) 1.42
Combination prevention: new hope for stopping the epidemic. Curr HIV/AIDS Rep (2013) 1.36
Pregnant Women's Knowledge of and Attitudes to HIV Testing at Komfo Anokye Teaching Hospital, Kumasi. Ghana Med J (2005) 1.28
The feasibility of preventing mother-to-child transmission of HIV using peer counselors in Zimbabwe. AIDS Res Ther (2008) 1.23
Barriers for introducing HIV testing among tuberculosis patients in Jogjakarta, Indonesia: a qualitative study. BMC Public Health (2008) 1.20
Factors shaping initial decision-making to self-test amongst cohabiting couples in urban Blantyre, Malawi. AIDS Behav (2014) 1.18
Determinants and prevalence of late HIV testing in Tijuana, Mexico. AIDS Patient Care STDS (2010) 1.08
Predictors of suboptimal virologic response to highly active antiretroviral therapy among human immunodeficiency virus-infected adolescents: analyses of the reaching for excellence in adolescent care and health (REACH) project. Arch Pediatr Adolesc Med (2009) 1.03
Hepatitis B screening in the Turkish-Dutch population in Rotterdam, the Netherlands; qualitative assessment of socio-cultural determinants. BMC Public Health (2009) 0.96
Syphilis in China: the great comeback. Emerg Health Threats J (2008) 0.95
Estimating HIV prevalence from surveys with low individual consent rates: annealing individual and pooled samples. Emerg Themes Epidemiol (2013) 0.87
Effect of rapid HIV testing on HIV incidence and services in populations at high risk for HIV exposure: an equity-focused systematic review. BMJ Open (2014) 0.86
To Test or Not to Test: Barriers and Solutions to Testing African American College Students for HIV at a Historically Black College/University. J Health Dispar Res Pract (2014) 0.84
Questioning context: a set of interdisciplinary questions for investigating contextual factors affecting health decision making. Health Expect (2010) 0.81
Marketing the HIV test to MSM: ethnic differences in preferred venues and sources. Health Promot Pract (2012) 0.81
Factors Associated with Lifetime HIV Testing in Texas by Race/Ethnicity. Open AIDS J (2012) 0.80
Knowing is not enough: a qualitative report on HIV testing among heterosexual African-American men. AIDS Care (2014) 0.78
The necessity of HIV testing in Iranian pregnant women and its ethical considerations. J Med Ethics Hist Med (2009) 0.75
Barriers and facilitators to HIV testing among young men who have sex with men and transgender women in Kingston, Jamaica: a qualitative study. J Int AIDS Soc (2017) 0.75
Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA (2007) 7.00
Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med (2003) 3.26
Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus. Arch Pediatr Adolesc Med (2005) 2.60
Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection. Antimicrob Agents Chemother (2007) 1.94
HIV-infected US youth are at high risk of obesity and poor diet quality: a challenge for improving short- and long-term health outcomes. J Am Diet Assoc (2004) 1.71
HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology (2004) 1.70
HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently. J Immunol (2006) 1.64
The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men. J Acquir Immune Defic Syndr (2013) 1.63
Delayed onset of pubertal development in children and adolescents with perinatally acquired HIV infection. J Acquir Immune Defic Syndr (2003) 1.60
HIV voluntary counseling and testing among injection drug users in south China: a study of a non-government organization based program. AIDS Behav (2007) 1.55
Vitamin D status in adolescents and young adults with HIV infection. Am J Clin Nutr (2006) 1.49
Host genetics and HIV-1 viral load set-point in African-Americans. AIDS (2009) 1.37
Human papillomavirus infection and abnormal cytology of the anus in HIV-infected and uninfected adolescents. AIDS (2003) 1.31
Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroads. J Acquir Immune Defic Syndr (2008) 1.26
CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides. AIDS (2005) 1.26
Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents. AIDS (2002) 1.24
Prevalence of primary HIV-1 drug resistance among recently infected adolescents: a multicenter adolescent medicine trials network for HIV/AIDS interventions study. J Infect Dis (2006) 1.16
Rates and correlates of antiretroviral therapy use and virologic suppression among perinatally and behaviorally HIV-infected youth linked to care in the United States. J Acquir Immune Defic Syndr (2015) 1.12
Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021. Clin Infect Dis (2010) 1.11
Immune reconstitution and predictors of virologic failure in adolescents infected through risk behaviors and initiating HAART: week 60 results from the PACTG 381 cohort. AIDS Res Hum Retroviruses (2006) 1.11
Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities. J Acquir Immune Defic Syndr (2003) 1.10
Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial. Clin Infect Dis (2012) 1.09
Glutathione, glutathione peroxidase, and selenium status in HIV-positive and HIV-negative adolescents and young adults. Am J Clin Nutr (2007) 1.06
Immune activation and oxidative damage in HIV-positive and HIV-negative adolescents. J Acquir Immune Defic Syndr (2005) 1.06
Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents. AIDS (2007) 1.05
Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women. Clin Infect Dis (2013) 1.05
Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection. J Clin Endocrinol Metab (2012) 1.04
Predictors of suboptimal virologic response to highly active antiretroviral therapy among human immunodeficiency virus-infected adolescents: analyses of the reaching for excellence in adolescent care and health (REACH) project. Arch Pediatr Adolesc Med (2009) 1.03
Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B. Clin Infect Dis (2012) 1.02
The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents. BMC Infect Dis (2010) 1.01
Interleukin-10 gene (IL10) polymorphisms and human papillomavirus clearance among immunosuppressed adolescents. Cancer Epidemiol Biomarkers Prev (2007) 0.99
Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infection in high-risk adolescents. J Infect Dis (2005) 0.98
Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency? Antimicrob Agents Chemother (2013) 0.97
Peripheral blood lymphocyte subsets in adolescents: a longitudinal analysis from the REACH project. Clin Diagn Lab Immunol (2002) 0.97
The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans. Hum Immunol (2011) 0.93
Assessment of thymic activity in human immunodeficiency virus-negative and -positive adolescents by real-time PCR quantitation of T-cell receptor rearrangement excision circles. Clin Diagn Lab Immunol (2003) 0.93
Calibration and validation of an oral fluid-based sensitive/less-sensitive assay to distinguish recent from established HIV-1 infections. J Clin Lab Anal (2007) 0.91
Human leukocyte antigen class I supertypes and HIV-1 control in African Americans. J Virol (2009) 0.88
Cytokine and chemokine gene polymorphisms among ethnically diverse North Americans with HIV-1 infection. J Acquir Immune Defic Syndr (2004) 0.88
Prevalence, incidence, and recurrence of oral lesions among HIV-infected patients on HAART in Alabama: a two-year longitudinal study. South Med J (2011) 0.88
Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy urban adolescents in the United States. Pediatr Infect Dis J (2010) 0.87
Vitamins C and E in adolescents and young adults with HIV infection. Am J Clin Nutr (2006) 0.87
Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth. Hum Genet (2009) 0.87
Substantial multiclass transmitted drug resistance and drug-relevant polymorphisms among treatment-naïve behaviorally HIV-infected youth. AIDS Patient Care STDS (2012) 0.87
Epidemiological and genetic correlates of incident Chlamydia trachomatis infection in North American adolescents. J Infect Dis (2004) 0.86
CD4+ and CD8+ T cell receptor repertoire perturbations with normal levels of T cell receptor excision circles in HIV-infected, therapy-naive adolescents. AIDS Res Hum Retroviruses (2003) 0.86
Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination. J Acquir Immune Defic Syndr (2012) 0.85
US youths in the early stages of HIV disease have low intakes of some micronutrients important for optimal immune function. J Am Diet Assoc (2004) 0.85
Toll-like receptor gene variants associated with bacterial vaginosis among HIV-1 infected adolescents. J Reprod Immunol (2012) 0.85
The relationships between substance abuse, psychosocial variables, and natural killer cell enumeration and function in HIV-infected and high-risk uninfected adolescents. AIDS Res Hum Retroviruses (2003) 0.84
Increased proliferation within T lymphocyte subsets of HIV-infected adolescents. AIDS Res Hum Retroviruses (2002) 0.84
Transitional probability-based model for HPV clearance in HIV-1-positive adolescent females. PLoS One (2012) 0.84
An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM. J Acquir Immune Defic Syndr (2017) 0.84
Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation. AIDS Res Hum Retroviruses (2012) 0.83
Interleukin-10 (IL-10) pathway: genetic variants and outcomes of HIV-1 infection in African American adolescents. PLoS One (2010) 0.83
Immunogenetic correlates of Neisseria gonorrhoeae infection in adolescents. Sex Transm Dis (2008) 0.83
Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061. J Acquir Immune Defic Syndr (2015) 0.83
TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency virus (HIV)-seropositive and HIV-seronegative youths. Clin Diagn Lab Immunol (2003) 0.82
T cell responses in HIV type 1-infected adolescent minorities share similar epitope specificities with whites despite significant differences in HLA class I alleles. AIDS Res Hum Retroviruses (2003) 0.81
CCR2 and CCR5 genotypes in HIV type 1-infected adolescents: limited contributions to variability in plasma HIV type 1 RNA concentration in the absence of antiretroviral therapy. AIDS Res Hum Retroviruses (2002) 0.81
Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents. Sex Transm Dis (2012) 0.79
Comprehension of a simplified assent form in a vaccine trial for adolescents. J Med Ethics (2013) 0.79
Contemporary profile of oral manifestations of HIV/AIDS and associated risk factors in a Southeastern US clinic. J Public Health Dent (2011) 0.79
Hepatitis B vaccination in HIV-infected youth: a randomized trial of three regimens. J Acquir Immune Defic Syndr (2011) 0.79
Cohort- and time-specific associations of CTLA4 genotypes with HIV-1 disease progression. AIDS (2006) 0.78
Variants in interleukin family of cytokines genes influence clearance of high risk HPV in HIV-1 coinfected African-American adolescents. Hum Immunol (2013) 0.78
Incident anal human papillomavirus and human papillomavirus-related sequelae in HIV-infected versus HIV-uninfected adolescents in the United States. Sex Transm Dis (2013) 0.78
Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein. Front Genet (2013) 0.78
Mitochondrial DNA diversity in the African American population. Mitochondrial DNA (2013) 0.78
Short-cycle therapy in adolescents after continuous therapy with established viral suppression: the impact on viral load suppression. AIDS Res Hum Retroviruses (2009) 0.78
Identification of three immunologic correlates for HIV type 1 pathogenesis in youth. AIDS Res Hum Retroviruses (2010) 0.78
Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate. Antivir Ther (2014) 0.77
Demographic profiles of newly acquired HIV infections among adolescents and young adults in the U.S. J Adolesc Health (2009) 0.77
Prevalence of proteinuria and elevated serum cystatin C among HIV-Infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) study. J Acquir Immune Defic Syndr (2012) 0.76
Plasma cytokines and oxidative damage in HIV-positive and HIV-negative adolescents and young adults: a protective role for IL-10? Free Radic Res (2005) 0.76
How we implemented an analytical support clinic to strengthen student research capacity in Zambia. Med Teach (2014) 0.75
Mitochondrial DNA variation and virologic and immunological HIV outcomes in African Americans. AIDS (2014) 0.75